Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features

Affiliations

¹ Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
² Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia.
³ Division of Endocrinology and Metabolism, New York University School of Medicine, New York.
⁴ Department of Pathology, Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor.
⁵ Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor.
⁶ Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison.
⁷ Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, Florida.

Yuri E Nikiforov et al. JAMA Oncol. 2018.

. 2018 Aug 1;4(8):1125-1126.

doi: 10.1001/jamaoncol.2018.1446.

¹ Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
² Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia.
³ Division of Endocrinology and Metabolism, New York University School of Medicine, New York.
⁴ Department of Pathology, Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor.
⁵ Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor.
⁶ Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison.
⁷ Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, Florida.

Abstract

This review of medical literature examines the criteria for diagnosis of noninvasive follicular thyroid neoplasm with papillarylike nuclear features.

Conflict of Interest Disclosures: None reported.

Follow-up of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Rosario PW, Mourão GF. Rosario PW, et al. Head Neck. 2019 Mar;41(3):833-834. doi: 10.1002/hed.25550. Epub 2019 Jan 24. Head Neck. 2019. PMID: 30676674 No abstract available.
Response to Letter to the Editor regarding follow-up for NIFTP.
Ferris RL, Nikiforov YE, Randolph G. Ferris RL, et al. Head Neck. 2019 Mar;41(3):835. doi: 10.1002/hed.25549. Epub 2019 Jan 24. Head Neck. 2019. PMID: 30677191 No abstract available.

1. Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023-1029. - PMC - PubMed
1. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment. Mod Pathol. 2016;29(7):698-707. - PubMed
1. Rosario PW, Mourão GF, Nunes MB, Nunes MS, Calsolari MR. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Endocr Relat Cancer. 2016;23(12):893-897. - PubMed
1. Xu B, Tallini G, Scognamiglio T, Roman BR, Tuttle RM, Ghossein RA. Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27(4):512-517. - PMC - PubMed
1. Parente DN, Kluijfhout WP, Bongers PJ, et al. Clinical safety of renaming encapsulated follicular variant of papillary thyroid carcinoma: is NIFTP truly benign? World J Surg. 2018;42(2):321-326. - PubMed